About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
JHEP Reports
›
Top Articles
JHEP Reports
Hepatology
,
Gastroenterology
10.3
(top 1%)
Impact Factor
11
(top 1%)
extended IF
24
(top 15%)
H-Index
589
authors
310
papers
2.9K
citations
565
citing journals
2.6K
citing authors
Most Cited Articles of JHEP Reports
Title
Year
Citations
Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper
2020
280
From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options
2019
116
Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism
2019
100
Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic
2020
68
Limitations of non-invasive tests for assessment of liver fibrosis
2020
54
Lifestyle modification in NAFLD/NASH: Facts and figures
2019
48
Non-alcoholic fatty liver disease in lean individuals
2019
47
Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease
2019
46
Global progress on the elimination of viral hepatitis as a major public health threat: An analysis of WHO Member State responses 2017
2019
42
The role of the gut microbiome in chronic liver disease: the clinical evidence revised
2019
41
Immunobiology of cholangiocarcinoma
2019
37
Liver cancer: A leading cause of cancer death in the United States and the role of the 1945-1965 birth cohort by ethnicity
2019
30
Beta-blockers in cirrhosis: Evidence-based indications and limitations
2020
30
Anticoagulation in the cirrhotic patient
2019
29
Epigenetics in hepatocellular carcinoma development and therapy: The tip of the iceberg
2020
27
Controversies in the management of hepatocellular carcinoma
2019
26
NAFLD and liver transplantation: Disease burden, current management and future challenges
2020
26
Radiotherapy for HCC: Ready for prime time?
2019
25
Where does TIPS fit in the management of patients with cirrhosis?
2020
25
Acute-on-chronic liver failure: Definitions, pathophysiology and principles of treatment
2021
25
Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group
2019
24
Liver toxicity as a limiting factor to the increasing use of immune checkpoint inhibitors
2020
23
knockout exacerbates diet-induced non-alcoholic steatohepatitis, fibrosis and liver injury in mice
2019
22
Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area
2021
22
Spleen stiffness to liver stiffness ratio significantly differs between ALD and HCV and predicts disease-specific complications
2019
21
0
1
2
next
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.